Copyright Reports & Markets. All rights reserved.

Global Radiopharmaceutical Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

Request for Sample of this report
Buy now

Table of Contents

    1 Industry Overview of Radiopharmaceutical

    • 1.1 Brief Introduction of Radiopharmaceutical
    • 1.2 Market Segmentation by Types
    • 1.3 Market Segmentation by Applications
    • 1.4 Market Dynamics of Radiopharmaceutical
      • 1.4.1 Market Drivers
      • 1.4.2 Market Challenges
      • 1.4.3 Market Opportunities
      • 1.4.4 Porter’s Five Forces
    • 1.5 Market Analysis by Countries of Radiopharmaceutical
      • 1.5.1 United States Status and Prospect (2015-2026)
      • 1.5.2 Canada Status and Prospect (2015-2026)
      • 1.5.3 Germany Status and Prospect (2015-2026)
      • 1.5.4 France Status and Prospect (2015-2026)
      • 1.5.5 UK Status and Prospect (2015-2026)
      • 1.5.6 Italy Status and Prospect (2015-2026)
      • 1.5.7 Russia Status and Prospect (2015-2026)
      • 1.5.8 Spain Status and Prospect (2015-2026)
      • 1.5.9 Netherlands Status and Prospect (2015-2026)
      • 1.5.10 Switzerland Status and Prospect (2015-2026)
      • 1.5.11 Belgium Status and Prospect (2015-2026)
      • 1.5.12 China Status and Prospect (2015-2026)
      • 1.5.13 Japan Status and Prospect (2015-2026)
      • 1.5.14 Korea Status and Prospect (2015-2026)
      • 1.5.15 India Status and Prospect (2015-2026)
      • 1.5.16 Australia Status and Prospect (2015-2026)
      • 1.5.17 Indonesia Status and Prospect (2015-2026)
      • 1.5.18 Thailand Status and Prospect (2015-2026)
      • 1.5.19 Philippines Status and Prospect (2015-2026)
      • 1.5.20 Vietnam Status and Prospect (2015-2026)
      • 1.5.21 Brazil Status and Prospect (2015-2026)
      • 1.5.22 Mexico Status and Prospect (2015-2026)
      • 1.5.23 Argentina Status and Prospect (2015-2026)
      • 1.5.24 Colombia Status and Prospect (2015-2026)
      • 1.5.25 Chile Status and Prospect (2015-2026)
      • 1.5.26 Peru Status and Prospect (2015-2026)
      • 1.5.27 Turkey Status and Prospect (2015-2026)
      • 1.5.28 Saudi Arabia Status and Prospect (2015-2026)
      • 1.5.29 United Arab Emirates Status and Prospect (2015-2026)
      • 1.5.30 South Africa Status and Prospect (2015-2026)
      • 1.5.31 Israel Status and Prospect (2015-2026)
      • 1.5.32 Egypt Status and Prospect (2015-2026)
      • 1.5.33 Nigeria Status and Prospect (2015-2026)

    2 Major Manufacturers Analysis of Radiopharmaceutical

    • 2.1 Company 1
      • 2.1.1 Company Profile
      • 2.1.2 Product Picture and Specifications
      • 2.1.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.1.4 Contact Information
    • 2.2 Company 2
      • 2.2.1 Company Profile
      • 2.2.2 Product Picture and Specifications
      • 2.2.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.2.4 Contact Information
    • 2.3 Company 3
      • 2.3.1 Company Profile
      • 2.3.2 Product Picture and Specifications
      • 2.3.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.3.4 Contact Information
    • 2.4 Company 4
      • 2.4.1 Company Profile
      • 2.4.2 Product Picture and Specifications
      • 2.4.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.4.4 Contact Information
    • 2.5 Company 5
      • 2.5.1 Company Profile
      • 2.5.2 Product Picture and Specifications
      • 2.5.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.5.4 Contact Information
    • 2.6 Company 6
      • 2.6.1 Company Profile
      • 2.6.2 Product Picture and Specifications
      • 2.6.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.6.4 Contact Information
    • 2.7 Company 7
      • 2.7.1 Company Profile
      • 2.7.2 Product Picture and Specifications
      • 2.7.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.7.4 Contact Information
    • 2.8 Company 8
      • 2.8.1 Company Profile
      • 2.8.2 Product Picture and Specifications
      • 2.8.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.8.4 Contact Information
    • 2.9 Company 9
      • 2.9.1 Company Profile
      • 2.9.2 Product Picture and Specifications
      • 2.9.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.9.4 Contact Information
    • 2.10 Company 10
      • 2.10.1 Company Profile
      • 2.10.2 Product Picture and Specifications
      • 2.10.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.10.4 Contact Information

    . . .

      3 Global Price, Sales and Revenue Analysis of Radiopharmaceutical by Regions, Manufacturers, Types and Applications

      • 3.1 Global Sales and Revenue of Radiopharmaceutical by Regions 2015-2020
      • 3.2 Global Sales and Revenue of Radiopharmaceutical by Manufacturers 2015-2020
      • 3.3 Global Sales and Revenue of Radiopharmaceutical by Types 2015-2020
      • 3.4 Global Sales and Revenue of Radiopharmaceutical by Applications 2015-2020
      • 3.5 Sales Price Analysis of Global Radiopharmaceutical by Regions, Manufacturers, Types and Applications in 2015-2020

      4 North America Sales and Revenue Analysis of Radiopharmaceutical by Countries

      • 4.1. North America Radiopharmaceutical Sales and Revenue Analysis by Countries (2015-2020)
      • 4.2 United States Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 4.3 Canada Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)

      5 Europe Sales and Revenue Analysis of Radiopharmaceutical by Countries

      • 5.1. Europe Radiopharmaceutical Sales and Revenue Analysis by Countries (2015-2020)
      • 5.2 Germany Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.3 France Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.4 UK Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.5 Italy Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.6 Russia Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.7 Spain Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.8 Netherlands Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.9 Switzerland Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 5.10 Belgium Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)

      6 Asia Pacific Sales and Revenue Analysis of Radiopharmaceutical by Countries

      • 6.1. Asia Pacific Radiopharmaceutical Sales and Revenue Analysis by Countries (2015-2020)
      • 6.2 China Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.3 Japan Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.4 Korea Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.5 India Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.6 Australia Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.7 Indonesia Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.8 Thailand Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.9 Philippines Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 6.10 Vietnam Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)

      7 Latin America Sales and Revenue Analysis of Radiopharmaceutical by Countries

      • 7.1. Latin America Radiopharmaceutical Sales and Revenue Analysis by Countries (2015-2020)
      • 7.2 Brazil Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 7.3 Mexico Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 7.4 Argentina Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 7.5 Colombia Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 7.6 Chile Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 7.7 Peru Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)

      8 Middle East & Africa Sales and Revenue Analysis of Radiopharmaceutical by Countries

      • 8.1. Middle East & Africa Radiopharmaceutical Sales and Revenue Analysis by Regions (2015-2020)
      • 8.2 Turkey Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 8.3 Saudi Arabia Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 8.4 United Arab Emirates Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 8.5 South Africa Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 8.6 Israel Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 8.7 Egypt Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)
      • 8.8 Nigeria Radiopharmaceutical Sales, Revenue and Growth Rate (2015-2020)

      9 Global Market Forecast of Radiopharmaceutical by Regions, Countries, Manufacturers, Types and Applications

      • 9.1 Global Sales and Revenue Forecast of Radiopharmaceutical by Regions 2021-2026
      • 9.2 Global Sales and Revenue Forecast of Radiopharmaceutical by Manufacturers 2021-2026
      • 9.3 Global Sales and Revenue Forecast of Radiopharmaceutical by Types 2021-2026
      • 9.4 Global Sales and Revenue Forecast of Radiopharmaceutical by Applications 2021-2026
      • 9.5 Global Revenue Forecast of Radiopharmaceutical by Countries 2021-2026
        • 9.5.1 United States Revenue Forecast (2021-2026)
        • 9.5.2 Canada Revenue Forecast (2021-2026)
        • 9.5.3 Germany Revenue Forecast (2021-2026)
        • 9.5.4 France Revenue Forecast (2021-2026)
        • 9.5.5 UK Revenue Forecast (2021-2026)
        • 9.5.6 Italy Revenue Forecast (2021-2026)
        • 9.5.7 Russia Revenue Forecast (2021-2026)
        • 9.5.8 Spain Revenue Forecast (2021-2026)
        • 9.5.9 Netherlands Revenue Forecast (2021-2026)
        • 9.5.10 Switzerland Revenue Forecast (2021-2026)
        • 9.5.11 Belgium Revenue Forecast (2021-2026)
        • 9.5.12 China Revenue Forecast (2021-2026)
        • 9.5.13 Japan Revenue Forecast (2021-2026)
        • 9.5.14 Korea Revenue Forecast (2021-2026)
        • 9.5.15 India Revenue Forecast (2021-2026)
        • 9.5.16 Australia Revenue Forecast (2021-2026)
        • 9.5.17 Indonesia Revenue Forecast (2021-2026)
        • 9.5.18 Thailand East Revenue Forecast (2021-2026)
        • 9.5.19 Philippines Revenue Forecast (2021-2026)
        • 9.5.20 Vietnam Revenue Forecast (2021-2026)
        • 9.5.21 Brazil Revenue Forecast (2021-2026)
        • 9.5.22 Mexico Revenue Forecast (2021-2026)
        • 9.5.23 Argentina Revenue Forecast (2021-2026)
        • 9.5.24 Colombia Revenue Forecast (2021-2026)
        • 9.5.25 Chile Revenue Forecast (2021-2026)
        • 9.5.26 Peru Revenue Forecast (2021-2026)
        • 9.5.27 Turkey Revenue Forecast (2021-2026)
        • 9.5.28 Saudi Arabia Revenue Forecast (2021-2026)
        • 9.5.29 United Arab Emirates Revenue Forecast (2021-2026)
        • 9.5.30 South Africa Revenue Forecast (2021-2026)
        • 9.5.31 Israel Revenue Forecast (2021-2026)
        • 9.5.32 Egypt Revenue Forecast (2021-2026)
        • 9.5.33 Nigeria Revenue Forecast (2021-2026)

      10 Industry Chain Analysis of Radiopharmaceutical

      • 10.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Radiopharmaceutical
        • 10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Radiopharmaceutical
        • 10.1.2 Major Equipment Suppliers with Contact Information Analysis of Radiopharmaceutical
      • 10.2 Downstream Major Consumers Analysis of Radiopharmaceutical
      • 10.3 Major Suppliers of Radiopharmaceutical with Contact Information
      • 10.4 Supply Chain Relationship Analysis of Radiopharmaceutical

      11 New Project Investment Feasibility Analysis of Radiopharmaceutical

      • 11.1 New Project SWOT Analysis of Radiopharmaceutical
      • 11.2 New Project Investment Feasibility Analysis of Radiopharmaceutical
        • 11.2.1 Project Name
        • 11.2.2 Investment Budget
        • 11.2.3 Project Product Solutions
        • 11.2.4 Project Schedule

      12 Conclusion of the Global Radiopharmaceutical Industry Market Professional Survey 2020

        13 Appendix

        • 13.1 Research Methodology
          • 13.1.1 Initial Data Exploration
          • 13.1.2 Statistical Model and Forecast
          • 13.1.3 Industry Insights and Validation
          • 13.1.4 Definitions and Forecast Parameters
        • 13.2 References and Data Sources
          • 13.2.1 Primary Sources
          • 13.2.2 Secondary Paid Sources
          • 13.2.3 Secondary Public Sources
        • 13.3 Abbreviations and Units of Measurement
        • 13.4 Author Details

        According to HJ Research's study, the global Radiopharmaceutical market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Radiopharmaceutical market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Radiopharmaceutical.

        Key players in global Radiopharmaceutical market include:
        Bayer
        Triad Isotopes
        Lantheus
        GE Healthcare
        Mallinckrodt
        Eli Lilly
        Bracco Imaging
        SIEMENS
        Navidea
        Nordion
        IBA Group
        Jubilant Pharma

        Market segmentation, by product types:
        Diagnostic Radioisotopes
        Therapeutic Radioisotopes

        Market segmentation, by applications:
        Oncology
        Cardiology
        Other

        Market segmentation, by regions:
        North America (United States, Canada)
        Europe (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium)
        Asia Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam)
        Middle East & Africa (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria)
        Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru)

        Reasons to get this report:
        In an insight outlook, this research report has dedicated to several quantities of analysis - industry research (global industry trends) and Radiopharmaceutical market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape, emerging and high-growth sections of Radiopharmaceutical market, high-growth regions, and market drivers, restraints, and also market chances.
        The analysis covers Radiopharmaceutical market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Radiopharmaceutical Market across sections such as also application and representatives.
        Additionally, the analysis also has a comprehensive review of the crucial players on the Radiopharmaceutical market together side their company profiles, SWOT analysis, latest advancements, and business plans.

        The report provides insights on the following pointers:
        1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Radiopharmaceutical industry.
        2. Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Radiopharmaceutical industry.
        3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam, Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria, Brazil, Mexico, Argentina, Colombia, Chile, Peru) market size (sales, revenue and growth rate) of Radiopharmaceutical industry.
        4. Different types and applications of Radiopharmaceutical industry, market share of each type and application by revenue.
        5. Global market size (sales, revenue) forecast by regions and countries from 2020 to 2026 of Radiopharmaceutical industry.
        6. Upstream raw materials and manufacturing equipment, downstream major consumers, industry chain analysis of Radiopharmaceutical industry.
        7. Key drivers influencing market growth, opportunities, the challenges and the risks analysis of Radiopharmaceutical industry.
        8. New Project Investment Feasibility Analysis of Radiopharmaceutical industry.
        Buy now